115 related articles for article (PubMed ID: 18398867)
1. Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro.
McCann MJ; Gill CI; Linton T; Berrar D; McGlynn H; Rowland IR
Mol Nutr Food Res; 2008 May; 52(5):567-80. PubMed ID: 18398867
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis.
McCann MJ; Rowland IR; Roy NC
Mol Nutr Food Res; 2013 Feb; 57(2):212-24. PubMed ID: 23148045
[TBL] [Abstract][Full Text] [Related]
3. Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.
Miura D; Saarinen NM; Miura Y; Santti R; Yagasaki K
Nutr Cancer; 2007; 58(1):49-59. PubMed ID: 17571967
[TBL] [Abstract][Full Text] [Related]
4. Lignans isolated from Campylotropis hirtella (Franch.) Schindl. decreased prostate specific antigen and androgen receptor expression in LNCaP cells.
Han HY; Wang XH; Wang NL; Ling MT; Wong YC; Yao XS
J Agric Food Chem; 2008 Aug; 56(16):6928-35. PubMed ID: 18656936
[TBL] [Abstract][Full Text] [Related]
5. Effect of mammalian lignans on the growth of prostate cancer cell lines.
Lin X; Switzer BR; Demark-Wahnefried W
Anticancer Res; 2001; 21(6A):3995-9. PubMed ID: 11911282
[TBL] [Abstract][Full Text] [Related]
6. Role of dietary lignans in the reduction of breast cancer risk.
Saarinen NM; Wärri A; Airio M; Smeds A; Mäkelä S
Mol Nutr Food Res; 2007 Jul; 51(7):857-66. PubMed ID: 17576639
[TBL] [Abstract][Full Text] [Related]
7. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women.
Morisset AS; Lemieux S; Veilleux A; Bergeron J; John Weisnagel S; Tchernof A
Br J Nutr; 2009 Jul; 102(2):195-200. PubMed ID: 19586570
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined lignan phytoestrogen and melatonin treatment on secretion of steroid hormones by adrenal carcinoma cells.
Fecteau KA; Eiler H; Oliver JW
Am J Vet Res; 2011 May; 72(5):675-80. PubMed ID: 21529220
[TBL] [Abstract][Full Text] [Related]
9. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway.
Chen LH; Fang J; Li H; Demark-Wahnefried W; Lin X
Mol Cancer Ther; 2007 Sep; 6(9):2581-90. PubMed ID: 17876055
[TBL] [Abstract][Full Text] [Related]
10. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo.
Saarinen NM; Penttinen PE; Smeds AI; Hurmerinta TT; Mäkelä SI
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):209-19. PubMed ID: 15860264
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20.
Abarzua S; Serikawa T; Szewczyk M; Richter DU; Piechulla B; Briese V
Arch Gynecol Obstet; 2012 Apr; 285(4):1145-51. PubMed ID: 22037685
[TBL] [Abstract][Full Text] [Related]
14. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
15. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
16. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
[TBL] [Abstract][Full Text] [Related]
17. [Phytoestrogenis properties of flaxseed lignans].
Martinchik AN; Zubtsov VV
Vopr Pitan; 2012; 81(6):61-6. PubMed ID: 23530438
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage.
McCann MJ; Rowland IR; Roy NC
Nutrients; 2014 Nov; 6(11):4839-55. PubMed ID: 25372501
[TBL] [Abstract][Full Text] [Related]
19. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
